Peregrine Pharmaceuticals (NASDAQ:PPHM)
| CAPS Rating |
|
|---|
PPHM
VS S&P 500 (SPY)
PPHM News and Commentary
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- 7 Reasons to Worry About Next Week – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- The 10 Most-Watched Diagnostic Substances Stocks – The Motley Fool
- Peregrine Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Peregrine Pharma's Secret Weapon – Minyanville
- A Simplified ASCO 2011 List for Biotech Investor Research – SeekingAlpha
- 3 Biotechs With Momentum Ahead of ASCO – SeekingAlpha
- 20 Stocks Under $3 With Significant Insider Buying – SeekingAlpha
How do you think PPHM will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
87
Outperform
9
Underperform
All-Star Players
11
Outperform
3
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
